
    
      The study is a prospective, randomized, controlled treatment design. The study device will be
      used for multiple daily injection (MDI) therapy of insulin. The participant will interact
      with the study device in the uncontrolled environment of the participant's daily life. The
      study protocol is designed to yield meaningful data to determine clinical and psychosocial
      benefits of using the study device. The study will evaluate the study device as an
      intervention versus a control group.
    
  